SHA:603229 Market Cap

SHA:603229 has a market cap or net worth of 7.60 billion as of June 13, 2025. Its market cap has increased by 9.86% in one year.

Market Cap

7.60B

Enterprise Value

6.79B

Revenue

801.01M

Ranking

n/a

PE Ratio

36.08

Stock Price

9.15

Market Cap Chart

Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 7.60B, an increase of 322.43%. That is a compound annual growth rate of 19.47%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	7.60B	-8.33%
Dec 31, 2024	8.29B	5.87%
Dec 29, 2023	7.83B	-18.09%
Dec 30, 2022	9.56B	-8.49%
Dec 31, 2021	10.45B	19.25%
Dec 31, 2020	8.76B	170.38%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	365.50B
Shenzhen Mindray Bio-Medical Electronics	285.11B
WuXi AppTec	186.63B
Sichuan Biokin Pharmaceutical	135.62B
Zhangzhou Pientzehuang Pharmaceutical.,	121.92B
Aier Eye Hospital Group	115.92B
Shanghai United Imaging Healthcare	108.05B
Yunnan Baiyao Group Co.,Ltd	100.99B

Market Cap Rankings